Please review the list below and check the companies, organizations and/or institutions with which you’re interested in engaging while in San Diego. Hover over each company name to read a brief overview. Limit 10 Selections.
Hover over each company name to read a brief overview
Ajinomoto Althea, Inc. is a fully integrated contract development and manufacturing organization providing clinical drug process development and manufacturing services to global biotechnology and pharmaceutical companies. Althea is a leading expert in aseptic filling of drug product in vials and syringes, and an industry leader for cGMP microbial-based manufacturing of recombinant proteins and plasmid DNA.
BioLabs is a membership-based network of shared lab facilities designed exclusively for high-potential, early-stage life sciences companies. It offers co-working environments that pair premium, fully equipped and supported lab and office space with unparalleled access to capital and industry partners.
Calibr is an independent not-for-profit institute with the goal of accelerating the translation of basic research to new medicines that address unmet medical needs. Global collaboration expedites this process and enables the formation of commercial partnerships, creating value that can then be reinvested on biomedical research.
COI Pharma provides Avalon Ventures’ portfolio companies intellectual and operational support by bringing together entrepreneurs, scientists, and industry mentors to collaborate on translating new scientific breakthroughs into novel therapeutics. COI provides a fully-equipped R&D infrastructure and eliminates operational noise, so teams can focus on drug discovery.
Dexcom is transforming diabetes care and management by providing superior continuous glucose monitoring technology to help patients and healthcare professionals better manage diabetes.
Eli Lilly was founded in 1876, dedicated to creating high-quality medicines that meet real needs in an era of unreliable elixirs peddled by questionable characters. 140 years later, the company remains committed to this vision by serving the people who take their medicines, and extending to health care professionals, employees and the community.
The Genomics Institute of the Novartis Research Foundation (GNF) serves as a bridge between basic science and preclinical drug discovery for Novartis’ global research organization, the Novartis Institutes for BioMedical Research (NIBR).
Human Longevity, Inc. (HLI) is the genomics-based, technology-driven company creating the world’s largest and most comprehensive database of whole genome, phenotype and clinical data. HLI is developing and applying large scale computing and machine learning to make novel discoveries to revolutionize the practice of medicine.
Illumina is a leading developer, manufacturer, and marketer of life sciences tools and integrated systems for large-scale analysis of genetic variation and function. These systems are enabling studies that were not even imaginable just a few years ago, and moving us closer to the realization of personalized medicine.
The J. Craig Venter Institute is a large multidisciplinary genomic-focused organization, with more than 250 scientists and staff and more than 250,000 square feet of laboratory space. A world leader in genomic research, it was formed in 2006 through the merger of The Institute for Genomic Research (TIGR), The Center for the Advancement of Genomics (TCAG), The J. Craig Venter Science Foundation, The Joint Technology Center, and the Institute for Biological Energy Alternatives (IBEA).
JLABS, part of Johnson & Johnson, is a network of open innovation research centers providing emerging companies with many of the advantages of being in a big company, without the capital investment. JLABS allows companies to pay only for the lab space and specialized equipment they need, with an option to quickly expand when they have the resources to do so.
Founded in 1988, the La Jolla Institute for Allergy & Immunology is one of only a few non-profit biomedical research institutes in the world focused on understanding the immune response to infectious agents and cancers and on advancing progress toward the prevention, treatment and cure of immune system diseases.
Moores Cancer Center is one of fewer than 50 National Cancer Institute-designated Comprehensive Cancer Centers in the US, and the only one in the San Diego region. The designation is reserved for centers with the highest achievements in cancer research, clinical care, education and community contributions.
Pfizer’s scientists based in La Jolla focus on two areas of research and development: discovering and developing new medicines to treat many forms of cancer; and, discovering novel prophylactic and therapeutic vaccines for the prevention and treatment of significant human maladies (in the areas of cancer and central nervous system diseases).
Founded in 2009, Renova Therapeutics is working to create a portfolio of definitive gene and peptide therapies to restore health to people suffering from cardiovascular and metabolic diseases, including congestive heart failure and type 2 diabetes.
SDSU’s Technology Transfer Office serves the needs of research faculty, allowing their research to impact the community beyond the University’s labs and classrooms. The TTO at SDSU is among the most productive small offices of its type as measured by royalties generated, number of invention and creative work disclosures, licenses executed, and startup companies spun out of the University.
In March 2006, the Burnham Biomedical Research Institute (subsequently renamed the Sanford-Burnham Medical Research Institute), the Salk Institute for Biological Studies, The Scripps Research Institute and the UC San Diego formed the San Diego Consortium for Regenerative Medicine and adopted the mission of expanding collaborative stem cell research and translating discoveries into clinical therapies and cures. After a donation of $30 million in 2008 it was renamed the Sanford Consortium for Regenerative Medicine. The La Jolla Institute for Allergy and Immunology became the fifth collaborating organization in 2011.
SBP is an independent, nonprofit institution conducting research in cancer, neuroscience, immunity and disorders of metabolism. SBP is home to one of the most comprehensive non-profit drug discovery platforms, is dedicated to research in childhood diseases, and pioneers advances in molecular stem cell research.
Synthetic Genomics Inc. (SGI) is a global leader in the fields of synthetic biology and synthetic genomics utilizing our foundational intellectual property in these rapidly evolving disciplines to design and build biological systems to solve global sustainability challenges.
TCAL is Takeda Pharmaceutical Company Limited’s innovative R&D center in San Diego. TCAL generates highly disease specific and patient tailored transformative new medicines aligned with Takeda’s global market strategies in Gastrointestinal, Central Nervous System and Immunology.
The Salk Institute is a private biomedical research institution dedicated to exploring the foundations of life and the molecular basis of diseases. Currently the institute is conducting pioneering research in cancer biology, metabolic disease, neuroscience, regenerative medicine, and plant biology. Salk science has provided the foundation for over 30 startup companies, many of which are still operating today.
The Scripps Research Institute (TSRI), one of the world’s largest, private, non-profit research organizations, stands at the forefront of basic biomedical science. It is internationally recognized for its research into immunology, molecular and cellular biology, chemistry, neurosciences, autoimmune diseases, cardiovascular diseases, virology, and synthetic vaccine development. Particularly significant is the institute’s study of the basic structure and design of biological molecules.
Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of $18 billion and more than 55,000 employees globally. We help our customers accelerate life sciencess research, solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity.
UC San Diego is recognized as a global leader in innovation, driving social and economic prosperity. Many departments and programs at UC San Diego collaborate with each other, with adjacent research institutions, and partner with regional industry and community organizations. Within this vibrant pioneering space, Research Affairs - Office of Innovation and Commercialization, accelerates the commercialization of UC San Diego innovations and contributes to a sustainable society, by empowering a diverse entrepreneurial culture on campus, and strengthening a dynamic regional innovation ecosystem.
In 2001, Vertex established its San Diego research and development site through the acquisition of Aurora Biosciences. At the San Diego site, Vertex scientists are focused on research efforts aimed at the discovery of new medicines for cystic fibrosis, pain, Huntington’s disease and other diseases.
Below is a list of organizations that provide resources on the investment opportunities and economic information on San Diego. Please review the list and check the organizations and/or institutions with which you’re interested in engaging while in San Diego. Hover over each company name to read a brief overview.
Hover over each company name to read a brief overview.
WTC San Diego cultivates a pipeline of export-ready firms, maximizes foreign direct investment opportunities, and enhances San Diego’s international identity in order to boost the region’s global fluency and competitiveness.
There are 18 cities within the San Diego region. By clicking this box, city officials in the region will be contacted to best connect your delegation.
Biocom is the largest, most experienced leader and advocate for California’s life sciencess industry. It works on behalf of 850 members to drive public policy, build an enviable network of industry leaders, create access to capital, introduce cutting-edge STEM education programs, and create robust value-driven purchasing programs.
SDVG makes it easier for high-quality San Diego companies to raise money while helping high-quality investors find and invest in San Diego companies. The group regularly meets with startup companies and investors in and outside of San Diego, while also managing an office in San Francisco.